论文部分内容阅读
[目的]分析新疆生产建设兵团第七师(七师)2010~2011年胃癌发病和死亡情况,为胃癌的防治提供科学依据。[方法]根据七师肿瘤登记处2010~2011年登记的恶性肿瘤发病及死亡资料,统计分析胃癌的粗发病率、粗死亡率、年龄别发病率、年龄别死亡率、中标率及世标率。[结果]2010~2011年七师胃癌新发病例67例,死亡病例47例。胃癌粗发病率为19.49/10万(男性26.91/10万,女性11.83/10万),中标率为9.67/10万,世标率为12.90/10万。胃癌粗死亡率为13.67/10万(男性22.33/10万,女性4.73/10万),中标率为6.44/10万,世标率为8.95/10万。胃癌发病率从50岁以后快速上升,并随着年龄的增长有上升趋势,在80~岁年龄组达到高峰,为194.66/10万;胃癌死亡率在50岁以后随着年龄的增长有上升趋势,在80~岁年龄组达到高峰,为139.04/10万。[结论]七师胃癌发病和死亡水平较低,应重点对男性及50岁以上的人群开展早诊早治,有效降低七师胃癌流行水平。
[Objective] To analyze the incidence and mortality of gastric cancer in 7th Division (7th Division) of Xinjiang Production and Construction Corps from 2010 to 2011, and provide a scientific basis for the prevention and treatment of gastric cancer. [Methods] According to the incidence and death data of malignant tumors registered from 2010 to 2011 of the 7th Division Tumor Registry, the crude incidence, crude mortality, age-specific morbidity, age-specific mortality, successful rate and world standard rate . [Results] There were 67 cases of newly diagnosed gastric cancer in seven divisions from 2010 to 2011, 47 cases of death. The crude incidence rate of gastric cancer was 19.49 / 100000 (male 26.91 / 100000, female 11.83 / 100000), the successful rate was 9.67 / 100000, the world standard rate was 12.90 / 100000. The crude death rate of gastric cancer was 13.67 / 100000 (22.33 / 100,000 men, 4.73 / 100000 women), the successful rate was 6.44 / 100000, the world standard rate was 8.95 / 100000. The incidence of gastric cancer increased rapidly from the age of 50 and increased with age, reaching the peak in the age group of 80 to 194.66 / 100 000. The gastric cancer mortality increased with age after 50 years of age , Peaked in the age group of 80 ~ 139.04 / 100,000. [Conclusion] The incidence and incidence of gastric cancer in the seven divisions is relatively low. Early diagnosis and early diagnosis and treatment of gastric cancer should be focused on males and over 50 years of age, effectively reducing the prevalence of gastric cancer in the seventh division.